ArticleClinical lymphoma, myeloma & leukemia2023

A Phase I Trial of Allogeneic γδ T Lymphocytes From Haploidentical Donors in Patients With Refractory or Relapsed Acute Myeloid Leukemia.

Jan Vydra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.